000181142 001__ 181142
000181142 005__ 20240229145641.0
000181142 0247_ $$2doi$$a10.1016/j.medj.2022.07.004
000181142 0247_ $$2pmid$$apmid:35963231
000181142 0247_ $$2altmetric$$aaltmetric:134064393
000181142 037__ $$aDKFZ-2022-01795
000181142 041__ $$aEnglish
000181142 082__ $$a610
000181142 1001_ $$0P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aPfister, Stefan$$b0$$eFirst author$$udkfz
000181142 245__ $$aPediatric precision oncology-Time for clinical prime time.
000181142 260__ $$aAmsterdam$$bElsevier$$c2022
000181142 3367_ $$2DRIVER$$aarticle
000181142 3367_ $$2DataCite$$aOutput Types/Journal article
000181142 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1674476886_24708
000181142 3367_ $$2BibTeX$$aARTICLE
000181142 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000181142 3367_ $$00$$2EndNote$$aJournal Article
000181142 500__ $$a#EA:B062#LA:B360# / Note
000181142 520__ $$aRecent prospective molecular tumor-profiling studies in pediatric cancer patients across a variety of different healthcare systems have highlighted both the feasibility and clinical utility of this approach. The current study by Church and colleagues in Nature Medicine1 has further substantiated this and laid the groundwork for a systematic collaborative approach to pediatric precision oncology in the US.
000181142 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000181142 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000181142 7001_ $$0P:(DE-He78)143af26de9d57bf624771616318aaf7c$$aWitt, Olaf$$b1$$udkfz
000181142 7001_ $$0P:(DE-He78)551bb92841f634070997aa168d818492$$aJones, David$$b2$$eLast author$$udkfz
000181142 773__ $$0PERI:(DE-600)3050845-9$$a10.1016/j.medj.2022.07.004$$gVol. 3, no. 8, p. 521 - 522$$n8$$p521 - 522$$tMed$$v3$$x2666-6340$$y2022
000181142 909CO $$ooai:inrepo02.dkfz.de:181142$$pVDB
000181142 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000181142 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)143af26de9d57bf624771616318aaf7c$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000181142 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)551bb92841f634070997aa168d818492$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000181142 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000181142 9141_ $$y2022
000181142 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-18
000181142 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-18
000181142 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-18
000181142 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2022-11-18
000181142 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-18
000181142 9202_ $$0I:(DE-He78)B360-20160331$$kB360$$lPediatric Glioma$$x0
000181142 9200_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000181142 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000181142 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000181142 9201_ $$0I:(DE-He78)B310-20160331$$kB310$$lKKE Pädiatrische Onkologie$$x2
000181142 9201_ $$0I:(DE-He78)B360-20160331$$kB360$$lPediatric Glioma$$x3
000181142 980__ $$ajournal
000181142 980__ $$aVDB
000181142 980__ $$aI:(DE-He78)B062-20160331
000181142 980__ $$aI:(DE-He78)HD01-20160331
000181142 980__ $$aI:(DE-He78)B310-20160331
000181142 980__ $$aI:(DE-He78)B360-20160331
000181142 980__ $$aUNRESTRICTED